Sensitivity to missing not at random dropout in clinical trials: use and interpretation of the Trimmed Means Estimator

Audinga-Dea Hazewinkel, Jack Bowden, Kaitlin H. Wade, Tom Palmer, Nicola Wiles, Kate Tilling
doi: https://doi.org/10.1101/2021.03.05.21252334

Article Information

doi 
https://doi.org/10.1101/2021.03.05.21252334
History 
  • March 8, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Audinga-Dea Hazewinkel1,2,*,
  2. Jack Bowden2,4,
  3. Kaitlin H. Wade1,2,
  4. Tom Palmer1,2,
  5. Nicola Wiles3 and
  6. Kate Tilling1,2
  1. 1Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K.
  2. 2Medical Research Council Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, U.K.
  3. 3Centre for Academic Mental Health, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K.
  4. 4Exeter Diabetes Group (ExCEED), College of Medicine and Health, University of Exeter, Exeter,U.K.
  1. ↵*Corresponding author; email: a.d.hazewinkel{at}bristol.ac.uk
Back to top
Posted March 08, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Sensitivity to missing not at random dropout in clinical trials: use and interpretation of the Trimmed Means Estimator
Audinga-Dea Hazewinkel, Jack Bowden, Kaitlin H. Wade, Tom Palmer, Nicola Wiles, Kate Tilling
medRxiv 2021.03.05.21252334; doi: https://doi.org/10.1101/2021.03.05.21252334
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area